In this study, the PathnSitu HER2/neu antibody for IHC staining was employed, utilizing specific criteria defined by Valtorta et al. [10], known as the HERACLES (HER2 Amplification for Colorectal cancer Enhanced Stratification) diagnostic criteria. The gene discussed is ERBB2; the disease is colorectal cancer.